# Famotidine

NDC: 70860-751
Generic name: famotidine
Labeler / Manufacturer: Athenex Pharmaceutical Division, LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200810
Marketing ended: 20260731
FDA application: ANDA075622

## Active ingredients

- FAMOTIDINE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70860-751"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70860-751
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=234d941f-5754-4d83-b02e-26638e0054e6